IRD
Opus Genetics, Inc.
NASDAQ · USHealthcareBiotechnology
$3.05-6.73%
Price as of Jul 20, 2026
IRD valuation
Opus Genetics, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 13.54x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -5.42x
- Price / sales
- 20.72x
- Price / cash flow
- -6.37x
Enterprise value
- Enterprise value
- $214.2M
- EV / sales
- 17.88x
- EV / EBITDA
- -2.05x
- EV / EBIT
- -4.98x
- Market cap
- $248.3M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.